Vericel Corporation (VCEL)
Last updated: 2026-10-24 06:47:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Vericel Corporation (VCEL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $42.53, with a market capitalization of $2.20B and a P/E ratio of 90.84. Over the past 52 weeks, its price has ranged from $28.95 to $49.32. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.20B | |
$42.99 | |
$68.94 | |
$1.69 | |
$42.97 | |
409.41K | |
512.55K | |
90.84 | |
$49.32 | |
$28.95 | |
-- | |
-- |
Vericel Corporation (VCEL) Latest Closing Stock Price
Vericel Corporation (VCEL) last closed at $42.97 as of 2026-10-23 23:31:00, unchanged from the previous close of $42.97.
During the latest regular trading session, VCEL traded between $1.69 and $68.94, with a volume of 409.41K shares. The closing price was near the middle and near the upper end of its 52-week range.
Vericel Corporation (VCEL) 7-Day Stock Price Change
Over the past seven days, Vericel Corporation (VCEL) moved from $41.02 to $42.53, representing a gain of 3.67% ($1.51).
The stock traded between $39.71 and $43.01 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 525.65 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
VCEL 52-Week Price Position
Position in Range: 66.6%
VCEL is currently trading at $42.53, placing it 66.6% of the way from its 52-week low of $28.95 to its 52-week high of $49.32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Vericel Corporation (VCEL)?
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Vericel Corporation Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 398 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Vericel Corporation (VCEL) Stock on MEXC
Eligible investors can buy real shares of Vericel Corporation (VCEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Vericel Corporation (VCEL) stock price today?
2.Is VCEL stock going up or down today?
3.What is VCEL pre-market price?
4.What is VCEL after-hours price?
5.Is VCEL stock trading now?
6.Where does VCEL sit relative to its 52-week high and low?
7.What sector is Vericel Corporation in?
8.What is Vericel Corporation's market capitalization and where is it listed?
9.How is VCEL valued in terms of P/E ratio and EPS?
10.Does Vericel Corporation pay a dividend?
Explore More US Stocks
Search Stocks
VCEL Stock Calculator
Estimate the value between VCEL shares and USD.
VCEL Shares to USD
1.00 VCEL shares = 42.526 USD
Calculations are estimates based on the latest available price and are for reference only.


